Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 9648798, 6 pages
http://dx.doi.org/10.1155/2016/9648798
Research Article

Risk Factors for the Requirement of Antenatal Insulin Treatment in Gestational Diabetes Mellitus

1Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
2Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Hyogo 670-8540, Japan

Received 21 June 2016; Revised 26 September 2016; Accepted 23 October 2016

Academic Editor: Kazuya Yamagata

Copyright © 2016 Mayu Watanabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, “International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy,” Diabetes Care, vol. 33, no. 3, pp. 676–682, 2010. View at Publisher · View at Google Scholar
  2. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Y. Seino, K. Nanjo et al., “Report of the committee on the classification and diagnostic criteria of diabetes mellitus,” Journal of Diabetes Investigation, vol. 1, no. 5, pp. 212–228, 2010. View at Publisher · View at Google Scholar
  3. E. A. Garrison and S. Jagasia, “Inpatient management of women with gestational and pregestational diabetes in pregnancy,” Current Diabetes Reports, vol. 14, no. 2, p. 457, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. B. Landon, C. Y. Spong, E. Thom et al., “A multicenter, randomized trial of treatment for mild gestational diabetes,” The New England Journal of Medicine, vol. 361, no. 14, pp. 1339–1348, 2009. View at Publisher · View at Google Scholar
  5. O. Langer, D. A. Rodriguez, E. M. Xenakis, M. B. McFarland, M. D. Berkus, and F. Arrendondo, “Intensified versus conventional management of gestational diabetes,” American Journal of Obstetrics & Gynecology, vol. 170, no. 4, pp. 1036–1047, 1994. View at Google Scholar
  6. C. A. Crowther, J. E. Hiller, J. R. Moss, A. J. McPhee, W. S. Jeffries, and J. S. Robinson, “Effect of treatment of gestational diabetes mellitus on pregnancy outcomes,” The New England Journal of Medicine, vol. 352, no. 24, pp. 2477–2486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. V. W. Wong and B. Jalaludin, “Gestational diabetes mellitus: who requires insulin therapy?” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 51, no. 5, pp. 432–436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. D. Sapienza, R. P. V. Francisco, T. C. Trindade, and M. Zugaib, “Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 88, no. 1, pp. 81–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Pertot, L. Molyneaux, K. Tan, G. P. Ross, D. K. Yue, and J. Wong, “Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus?” Diabetes Care, vol. 34, no. 10, pp. 2214–2216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Meshel, E. Schejter, T. Harel et al., “Can we predict the need for pharmacological treatment according to demographic and clinical characteristics in gestational diabetes?” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 29, no. 13, pp. 2062–2066, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Bakiner, “Risk factors that can predict antenatal insulin need in gestational diabetes,” Journal of Clinical Medicine Research, vol. 5, no. 5, pp. 381–388, 2013. View at Publisher · View at Google Scholar
  12. K. Baptiste-Roberts, B. B. Barone, T. L. Gary et al., “Risk Factors for type 2 diabetes among women with gestational diabetes: a systematic review,” American Journal of Medicine, vol. 122, no. 3, pp. 207.e4–214.e4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ikenoue, K. Miyakoshi, Y. Saisho et al., “Clinical impact of women with gestational diabetes mellitus by the new consensus criteria: two year experience in a single institution in Japan,” Endocrine Journal, vol. 61, no. 4, pp. 353–358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Saisho, K. Miyakoshi, M. Tanaka et al., “Beta cell dysfunction and its clinical significance in gestational diabetes,” Endocrine Journal, vol. 57, no. 11, pp. 973–980, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Akinci, A. Celtik, S. Yener, and S. Yesil, “Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?” Diabetes Research and Clinical Practice, vol. 82, no. 2, pp. 219–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Black, D. A. Sacks, A. H. Xiang, and J. M. Lawrence, “The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth,” Diabetes Care, vol. 36, no. 1, pp. 56–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Ogawa, Y. Matsuda, A. Kobayashi et al., “Ritodrine should be carefully administered during antenatal glucocorticoid therapy even in nondiabetic pregnancies,” ISRN Obstetrics and Gynecology, vol. 2013, Article ID 120735, 4 pages, 2013. View at Publisher · View at Google Scholar
  18. M. Hirai, I. Yasuhi, T. Ishimaru, T. Yamabe, and K. Kubota, “Effect of prolonged intravenous ritodrine tocolysis on diurnal glucose profiles in pregnant women with normal carbohydrate tolerance,” Nihon Sanka Fujinka Gakkai Zasshi, vol. 48, no. 7, pp. 488–494, 1996. View at Google Scholar · View at Scopus
  19. The Canadian Preterm Labor Investigators Group, “Treatment of preterm labor with the beta-adrenergic agonist ritodrine,” The New England Journal of Medicine, vol. 327, no. 5, pp. 308–312, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Minakami and I. Sato, “Reestimating date of delivery in multifetal pregnancies,” The Journal of the American Medical Association, vol. 275, no. 18, pp. 1432–1434, 1996. View at Publisher · View at Google Scholar · View at Scopus